Infectious Diseases

Experimental Drug Effectively Treats S. Aureus Infections

Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while reducing the possibility of patients developing antibiotic resistance.

For more videos, visit our partners at The Doctor's Channel.

Submit Feedback